305 related articles for article (PubMed ID: 9467944)
1. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
2. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
3. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
8. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
9. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico-pathological characterization.
Palmqvist R; Stenling R; Oberg A; Landberg G
J Pathol; 1999 May; 188(1):18-23. PubMed ID: 10398135
[TBL] [Abstract][Full Text] [Related]
11. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
[TBL] [Abstract][Full Text] [Related]
12. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
13. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
14. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
Geisen C; Karsunky H; Yücel R; Möröy T
Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
[TBL] [Abstract][Full Text] [Related]
15. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
Sgambato A; Cittadini A; Faraglia B; Weinstein IB
J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
19. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
[TBL] [Abstract][Full Text] [Related]
20. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
